FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Court Wont End Vanda Clinical Hold

Attorney Sara Koblitz says it shouldnt have required litigation to force FDA to respond fully to issues raised by Vanda over animal trials for its tra...

Marketing

Pfizer Settles Oregon Marketing Suit for $975,000

Oregon attorney general Ellen Rosenblum says Pfizer is paying $975,000 to settle state charges it distributed misleading marketing materials and coupo...

Human Drugs

China Business Owner Sentenced in Supplement Scheme

A Dallas federal court sentences a Shanghai, China business owner to 18 months imprisonment and one year of supervised release in connection with a sc...

Medical Devices

Stakeholders Want Cybersecurity Guidance Changes

Two stakeholders ask FDA for clarifications and changes to a draft guidance on content of premarket submissions for managing cybersecurity in medical ...

Federal Register

Guide on Pediatric HIV Drug Development

Federal Register notice: FDA makes available a final guidance entitled Pediatric HIV Infection: Drug Product Development for Treatment.

Human Drugs

HHS Advancing DTC Pricing Disclosure Rulemaking

HHSs Centers for Medicare & Medicaid Services submits to OMB for review a proposed rule to require including drugs list prices in direct-to-consumer a...

Human Drugs

Researchers Develop MRI-Friendly Protein Micelle

New York University researchers say they have developed nanoscale protein micelles that can both deliver drug therapy and be tracked by MRI.

Medical Devices

NEST Real-World Evidence Activities Updated

CDRH director Jeffrey Shuren updates work of the National Evaluation System for health Technology in assessing how real-world evidence can be used to ...

Medical Devices

Siemens Mobilett X-ray System Cleared

FDA clears a Siemens Healthineers 510(k) for the Mobilett Elara Max mobile X-ray system, which features improved information technology security as we...

Human Drugs

FDA OKs Losartan with NMBA Below 9.82 PPM

FDA says it is allowing temporary distribution of losartan with NMBA levels up to 9.82 ppm to ease a supply shortage.